about
Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey.Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy.Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.The major stressful life events and cancer: stress history and cancer.Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer.The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment.Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.Carbon-14 urea breath test: does it work in patients with partial gastric resection?The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients.Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival.The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer.Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience.The effect of tumor size on overall survival in patients with pT3 gastric cancer: experiences from 3 centers.Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA).MEFV gene testing may guide physicians for early diagnosis of familial Mediterranean fever.Endoscopic findings of dyspeptic patients unresponsive to proton pump inhibitors.Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients.HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples.Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.Port needles: do they need to be removed as frequently in infusional chemotherapy?Neoplastic diseases prevalence in a turkish university hospitalAttitude toward genetic testing for cancer risk in IstanbulD-dimer--can it be a marker for malignant gastric lesions?Conjunctival malt lymphoma successfully treated with single agent rituximab therapyWhat is the optimal number of lymph nodes to be dissected in colorectal cancer surgery?ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup studyThe prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomyEfficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-studyClinical importance of phosphatase of regenerating liver-3 expression in breast cancerEctopic breast carcinomaSjögren's syndrome and mean platelet volumeThe changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancerThe clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classificationPTK-7 Expression in Gastric Cancer: A Prognostic Determinant
P50
Q30978996-4FB36E66-A4A4-4260-9957-992AD8A922CFQ33684812-E5C57D67-82E6-42FD-A53F-A66072336500Q37887550-D1A5808A-5DC6-44B7-B603-F550623AF7E3Q38736629-AECA52A4-DB5F-4C77-AB09-386C30ACB242Q39720261-3EFC69BC-65BE-4EEF-BC1C-EE0B5A408421Q39764354-CE09F61C-EE0F-45AC-AD64-CBB29787B6B7Q39875624-6C4BDAAB-558F-4886-8D08-871A13C8C8D5Q39936604-B888BC51-752E-4B2C-A552-5134017102B9Q40339134-69E99679-6D76-40DB-9405-87830D24B616Q41102101-40A0B254-474F-44B8-B426-799DC685D31CQ41231669-05DD39A9-B1BF-4437-B6A0-403EE8F9B0D6Q41231684-72B2689E-81E6-4B2C-895A-160CF97BB4BAQ41664517-5C20776A-845E-4D43-8074-6C8761854EB3Q44234795-6591DB46-05DC-4655-A3B4-8DEAD3AE9C4AQ45986612-FAF8E87D-520E-47C5-A378-7C491179468DQ47402840-4900ED30-80D1-4B46-B152-1D8AC4FF3A30Q49888849-BC20AB36-D93C-4592-9514-9735224D13F9Q50122752-1E32DE2D-B40B-47E2-915A-31A2EB2A8364Q51062506-C4F32599-AD3E-4C1B-9C82-51CDA34E3361Q53216825-E8960D85-7F8A-49EF-B297-D0B08CBDFF0CQ53570246-FE0F43AF-3FF0-4712-8486-B0DF2FBABCC9Q53573656-17FAC258-F419-4D9C-9556-D2B45AA01425Q73687603-16B20F27-8557-4675-A986-9A6D190D1107Q80114954-1F7FE7FB-7AE2-45C0-BD7B-206659B73A8CQ80521251-A92DAE74-850E-445F-AB29-FD0025687AE1Q81515452-6825F024-09EA-4794-AC70-9F2FE991D447Q81695868-C8B4D1A9-12E9-4820-B1D4-3496CC0216F3Q81835175-3D0DDEF4-5E4E-4F9A-884D-8D758A506401Q83181397-B5D23D88-3F20-4957-91DE-4A5DD40C296DQ83945505-6BCEDB7B-ED0B-4D35-A767-8871CDD054ABQ84568221-693BC704-87DB-4291-90DD-F4FD7CA99560Q84705036-B9720F26-8EDC-4151-BA64-D50C6B7A357BQ84847268-F9C0B436-D722-4142-87E2-5DD1BF96350DQ85546461-5845BF2C-FF78-4688-A4C4-27DDF4587A58Q85716944-06EDE33C-53ED-4B5C-9FC4-FC9C7DF0AFB3Q86392578-3B3DDCF9-3BEF-404E-8323-437C30EE3A60Q88253573-6C28D4BB-BAF0-4460-8239-7A7FB59C1275Q91839621-C17E42AD-DB64-4439-B8AA-DAF9022B9A54
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
M Aliustaoglu
@ast
M Aliustaoglu
@en
M Aliustaoglu
@es
M Aliustaoglu
@nl
type
label
M Aliustaoglu
@ast
M Aliustaoglu
@en
M Aliustaoglu
@es
M Aliustaoglu
@nl
prefLabel
M Aliustaoglu
@ast
M Aliustaoglu
@en
M Aliustaoglu
@es
M Aliustaoglu
@nl
P106
P1153
56088782400
P31
P496
0000-0003-0287-0766